Zhu, Y., Liu, M., Fan, X., Xu, Y., Diao, X., Bi, J., Wan, X., Assaraf, Y. G., Kwok, H. F., Chen, L.

Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma

24 de March de 2026 by Zhu, Y., Liu, M., Fan, X., Xu, Y., Diao, X., Bi, J., Wan, X., Assaraf, Y. G., Kwok, H. F., Chen, L.

Background
Immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) immunotherapies have revolutionized the treatment of hepatocellular carcinoma (HCC). However, the frequent emergence of treatment resistance significantly limi…